Viral vectors in the treatment of Parkin
β
David S. Latchman; Robert S. Coffin
π
Article
π
2000
π
John Wiley and Sons
π
English
β 88 KB
π 2 views
s disease is an obvious target for the development of gene therapy procedures which could involve both the delivery of the gene encoding tyrosine hydroxylase to boost dopamine production or the delivery of genes encoding neurotrophic factors such as GDNF to promote the survival of dopaminergic neuro